◆英語タイトル：Reata Pharmaceuticals Inc (RETA) - Financial and Strategic SWOT Analysis Review
Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company that develops innovative medicines for the treatment of serious and life-threatening diseases. The company’s clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription factor, for restoring mitochondrial function, reducing oxidative stress, and resolving inflammation. Reata is evaluating bardoxolone methyl in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH), Alport syndrome and other kidney diseases; and omaveloxolone in Friedreich’s ataxia. The company works in partnership with academics, biotechnology and pharmaceutical companies to develop technologies, which disrupt the pathophysiological processes that lead to intractable diseases. Reata is headquartered in Irving, Texas, the US.
Reata Pharmaceuticals Inc Key Recent Developments
Feb 28,2019: Reata Pharmaceuticals announces fourth quarter and full year 2018 financials and operating results
Feb 19,2019: NephCure Kidney International Launches Revolutionary Clinical Trial Discovery Tool For Kidney Diseases
Jan 07,2019: Reata Pharmaceuticals names Geoffrey A. Block, M.D. as Vice President, Nephrology
Nov 07,2018: Reata Pharmaceuticals announces third quarter 2018 financial results and an update on development programs
Aug 08,2018: Reata Pharmaceuticals announces second quarter 2018 financial results and an update on development programs
This comprehensive SWOT profile of Reata Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Reata Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Reata Pharmaceuticals Inc – Key Information
Reata Pharmaceuticals Inc – Overview
Reata Pharmaceuticals Inc – Key Employees
Reata Pharmaceuticals Inc – Key Employee Biographies
Reata Pharmaceuticals Inc – Key Operational Heads
Reata Pharmaceuticals Inc – Major Products and Services
Reata Pharmaceuticals Inc – History
Reata Pharmaceuticals Inc – Company Statement
Reata Pharmaceuticals Inc – Locations And Subsidiaries
Reata Pharmaceuticals Inc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Reata Pharmaceuticals Inc – Business Description
Reata Pharmaceuticals Inc – Corporate Strategy
Reata Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Reata Pharmaceuticals Inc – Strengths
Reata Pharmaceuticals Inc – Weaknesses
Reata Pharmaceuticals Inc – Opportunities
Reata Pharmaceuticals Inc – Threats
Reata Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Reata Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Reata Pharmaceuticals Inc, Key Information
Reata Pharmaceuticals Inc, Key Ratios
Reata Pharmaceuticals Inc, Share Data
Reata Pharmaceuticals Inc, Major Products and Services
Reata Pharmaceuticals Inc, History
Reata Pharmaceuticals Inc, Key Employees
Reata Pharmaceuticals Inc, Key Employee Biographies
Reata Pharmaceuticals Inc, Key Operational Heads
Reata Pharmaceuticals Inc, Other Locations
Reata Pharmaceuticals Inc, Subsidiaries
Reata Pharmaceuticals Inc, Key Manufacturing facilities
Reata Pharmaceuticals Inc, Key Competitors
Reata Pharmaceuticals Inc, SWOT Analysis
Reata Pharmaceuticals Inc, Ratios based on current share price
Reata Pharmaceuticals Inc, Annual Ratios
Reata Pharmaceuticals Inc, Interim Ratios
Capital Market Ratios
List of Figures
Reata Pharmaceuticals Inc, Performance Chart
Reata Pharmaceuticals Inc, Ratio Charts
| ★海外企業調査レポート[Reata Pharmaceuticals Inc (RETA)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら